Vaccines based on the use of mva

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/863 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2595629

The present invention is directed to a recombinant MVA, which carries a nucleic acid sequence coding for a fusion protein. The present invention is further directed to a kit of parts containing said recombinant MVA as well as to a method for enhancing T cell responses in a mammal.

La présente invention concerne un MVA recombiné, qui comporte une séquence nucléotidique codant pour une protéine de fusion. La présente invention concerne en outre un kit en plusieurs parties contenant ledit MVA recombiné ainsi qu'un procédé d'amplification des réponses des lymphocytes T chez un mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccines based on the use of mva does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines based on the use of mva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines based on the use of mva will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2010789

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.